SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-15-011477
Filing Date
2015-12-14
Accepted
2015-12-14 07:45:13
Documents
2
Period of Report
2015-12-14
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K atra-8k_20151214.htm 8-K 30349
2 EX-99.1 atra-ex991_6.htm EX-99.1 18869
  Complete submission text file 0001564590-15-011477.txt   50371
Mailing Address 701 GATEWAY BLVD SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD SUITE 200 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36548 | Film No.: 151284754
SIC: 2836 Biological Products, (No Diagnostic Substances)